New data showed that an estimated 107,500 people, mostly children younger than 5 years of age, died of measles in 2023 which is an 8% decrease from the previous year, while far too many children are still dying from this preventable disease.
The World Health Organization (WHO) and United States Centers for Disease Control and Prevention (CDC) made this known on the embargo version of the progress toward measles elimination Worldwide, 2000-2023.
While added that this slight reduction in deaths was mainly because the surge in cases occurred in countries and regions where children with measles are less likely to die, due to better nutritional status and access to health services.
According to them, “Measles is preventable with two doses of measles vaccine; yet more than 22 million children missed their first dose of measles vaccine in 2023.
“Globally, an estimated 83% of children received their first dose of measles vaccine last year, while only 74% received the recommended second dose.
In his reaction, the WHO Director-General, Dr Tedro Ghebreyesus said Measles vaccine has saved more lives than any other vaccine in the past 50 years. To save even more lives and stop this deadly virus from harming the most vulnerable, we invest in immunization for every person, no matter where they live”.
“The number of measles infections are rising around the globe, endangering lives and health,” CDC Director Mandy Cohen said. “The measles vaccine is our best protection against the virus, and we must continue to invest in efforts to increase access.”
As measles cases surge and outbreaks increase, the world’s elimination goal, as laid out in Immunization Agenda 2030, is under threat. Worldwide, 82 countries had achieved or maintained measles elimination at end of 2023.
Urgent and targeted efforts by countries and partners, particularly in the African and Eastern Mediterranean regions, and in fragile, conflict-affected and vulnerable settings, are needed to vaccinate all children fully with two doses of measles vaccine.
This requires achieving and maintaining high-performing routine immunization programmes and delivering high-quality, high-coverage campaigns when those programmes are not yet sufficient to protect every child.
Countries and global immunization partners must also strengthen disease surveillance, including the Global Measles Rubella Laboratory Network (GMRLN).
Strong disease surveillance is critical to optimizing immunization programmes and detecting and responding rapidly to measles outbreaks in order to mitigate their size and impact.